1. Rivaroxaban with or without aspirin in stable cardiovascular disease;Eikelboom;N Engl J Med,2017
2. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study;Ozcan;Eur Heart J Cardiovasc Pharmacother,2018
3. Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists;Sorensen;Eur Heart J Cardiovasc Pharmacother,2017
4. ARAPACIS Study Investigators. Prevalence of peripheral artery disease by abnormal ankle–brachial index in atrial fibrillation: implications for risk and therapy;Violi;J Am Coll Cardiol,2013
5. Rivaroxaban for stroke prevention after embolic stroke of undetermined source;Hart;N Engl J Med,2018